Lenvatol Capsules

Name: Lenvatol Capsules
Brand: JEEDNYA PHARMA
Price: 1500 INR
Availability: InStock

1500 INR/Tablet

Get a Price/Quote

Product Details:

Dosage Form Capsule
Indication Treatment of thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma
Salt Composition Lenvatinib
Feature Targeted therapy, kinase inhibitor
Ingredients Lenvatinib mesylate, excipients
Application Oral administration for cancer treatment
Physical Color/Texture White to off-white hard gelatin capsule
Click to View more
Share Your Product:

Request to Call Back Send Inquiry

Lenvatol Capsules Price And Quantity

Minimum Order Quantity 100 Tablet
Price 1500 INR/Tablet

Lenvatol Capsules Product Specifications

Physical Color/Texture White to off-white hard gelatin capsule
Fermentation Smell Odorless or characteristic pharma odor
Feature Targeted therapy, kinase inhibitor
Indication Treatment of thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma
Shelf Life 24 months
Application Oral administration for cancer treatment
Ingredients Lenvatinib mesylate, excipients
Dosage Form Capsule
Storage Instructions Store below 30C, protect from light and moisture
Salt Composition Lenvatinib

Product Description

Lenvatol Capsules contain the active ingredient lenvatinib, a medication used in the treatment of thyroid cancer, kidney cancer, and liver cancer. By inhibiting the growth of cancer cells and cutting off their blood supply, Lenvatol Capsules slow down the progression of cancer and improve overall survival rates. Taken orally as directed by a healthcare professional, these capsules offer hope and extended quality of life to patients battling advanced cancers, providing a valuable treatment option in their fight against this challenging condition.

Precision Therapy for Advanced Cancer

Lenvatol Capsules provide a targeted approach to cancer therapy by inhibiting specific kinases involved in tumor growth and angiogenesis. This specialized action is suitable for managing advanced thyroid, kidney, and liver cancers. Administered orally, Lenvatol ensures more convenient dosing and consistent absorption, delivering measurable benefits for eligible patients as part of their prescribed treatment regimen.

Quality and Safety for Patient Confidence

Lenvatol is protected in moisture-resistant packaging and should be stored below 30C, away from light, to maintain its potency. Prescription use only and close medical supervision help ensure that patients receive the correct dosage tailored to their needs while minimizing adverse effects. The product undergoes rigorous quality measures before export and supply.

FAQ's of Lenvatol Capsules:

Q: How should Lenvatol Capsules be administered for effective cancer treatment?

A: Lenvatol Capsules are taken orally once daily, with or without food, exactly as prescribed by your healthcare professional. Do not open or crush the capsules; swallow them whole with water.

Q: What cancers are Lenvatol Capsules indicated for?

A: Lenvatol is indicated for the treatment of thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma, under the guidance of a specialist oncologist.

Q: When should Lenvatol Capsules be avoided?

A: Do not use Lenvatol if you have hypersensitivity to lenvatinib or any capsule ingredients. It is also not recommended during pregnancy or breastfeeding unless your doctor specifically advises its use.

Q: Where should Lenvatol Capsules be stored to ensure maximum effectiveness?

A: Store Lenvatol Capsules below 30C, protected from humidity and direct light, in their original packaging to maintain their stability and efficacy.

Q: What precautions must I take while using Lenvatol Capsules?

A: Use Lenvatol strictly under medical supervision. Inform your doctor of any existing conditions or if you are pregnant or planning pregnancy. Regular lab tests may be necessary to monitor your response and manage side effects.

Q: How does Lenvatol benefit cancer patients?

A: Lenvatol offers targeted cancer therapy by blocking certain proteins that promote tumor growth, potentially slowing disease progression and improving patient outcomes.